Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy, tolerability, and safety of teverelix DP in patients with advanced prostate cancer: A multicenter, open-label, phase 2 trial.
Prostate. 2024 May;84(6):584-598. doi: 10.1002/pros.24674. Epub 2024 Feb 4.
Prostate. 2024.
PMID: 38311868
Clinical Trial.
Safety, Pharmacokinetic and Pharmacodynamic Evaluation of Teverelix for the Treatment of Hormone-Sensitive Advanced Prostate Cancer: Phase 2 Loading-Dose-Finding Studies.
MacLean CM, Ulys A, Jankevičius F, Saladžinskas Ž, van Os S, Larsen F.
MacLean CM, et al.
Medicina (Kaunas). 2023 Mar 29;59(4):681. doi: 10.3390/medicina59040681.
Medicina (Kaunas). 2023.
PMID: 37109639
Free PMC article.
Clinical Trial.
Item in Clipboard
Pharmacokinetic, Safety, and Pharmacodynamic Properties of Teverelix Trifluoroacetate, a Novel Gonadotropin-Releasing Hormone Antagonist, in Healthy Adult Subjects.
MacLean CM, Godsafe Z, Soto-Forte P, Larsen F.
MacLean CM, et al.
Clin Pharmacol Drug Dev. 2022 Feb;11(2):257-269. doi: 10.1002/cpdd.1008. Epub 2021 Aug 26.
Clin Pharmacol Drug Dev. 2022.
PMID: 34448368
Clinical Trial.
Item in Clipboard
Effect of food on the pharmacokinetics and pharmacodynamics of an oral ghrelin agonist (ARD-07) in healthy subjects.
MacLean CM, Casanova AT, Baselgia-Jeker L, Neave N, Larsen F, Skillern L, Drewe J, Beglinger C.
MacLean CM, et al.
J Clin Pharmacol. 2009 May;49(5):553-9. doi: 10.1177/0091270008330160. Epub 2009 Mar 17.
J Clin Pharmacol. 2009.
PMID: 19293342
Clinical Trial.
Item in Clipboard
Cite
Cite